We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · October 11, 2020

Regorafenib After Failure of Gemcitabine and Platinum-Based Chemotherapy for Advanced Biliary Tumors

Annals of Oncology

 

Additional Info

Annals of Oncology
Regorafenib After Failure of Gemcitabine and Platinum-Based Chemotherapy for Locally Advanced/Metastatic Biliary Tumors: REACHIN, a Randomized, Double-Blind, Phase II Trial
Ann. Oncol 2020 Sep 01;31(9)1169-1177, A Demols, I Borbath, M Van den Eynde, G Houbiers, M Peeters, R Marechal, T Delaunoit, JC Goemine, S Laurent, S Holbrechts, M Paesmans, JL Van Laethem

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading